113 related articles for article (PubMed ID: 10811537)
41. Cerebral small-vessel disease and decline in information processing speed, executive function and memory.
Prins ND; van Dijk EJ; den Heijer T; Vermeer SE; Jolles J; Koudstaal PJ; Hofman A; Breteler MM
Brain; 2005 Sep; 128(Pt 9):2034-41. PubMed ID: 15947059
[TBL] [Abstract][Full Text] [Related]
42. Prevalence and Risk Factors of Brain Infarcts and Associations With Cognitive Performance in Tenants of Marginal Housing.
Zhou LW; Panenka WJ; Jones AA; Gicas KM; Thornton AE; Heran MKS; Volders D; Lang DJ; Vertinsky AT; Rauscher A; Su W; Barr AM; MacEwan GW; Honer WG; Field TS
J Am Heart Assoc; 2019 Jul; 8(13):e011412. PubMed ID: 31242796
[TBL] [Abstract][Full Text] [Related]
43. Preliminary evidence that estrogen protects against age-related hippocampal atrophy.
Eberling JL; Wu C; Haan MN; Mungas D; Buonocore M; Jagust WJ
Neurobiol Aging; 2003 Sep; 24(5):725-32. PubMed ID: 12885580
[TBL] [Abstract][Full Text] [Related]
44. Early cerebral small vessel disease and brain volume, cognition, and gait.
Smith EE; O'Donnell M; Dagenais G; Lear SA; Wielgosz A; Sharma M; Poirier P; Stotts G; Black SE; Strother S; Noseworthy MD; Benavente O; Modi J; Goyal M; Batool S; Sanchez K; Hill V; McCreary CR; Frayne R; Islam S; DeJesus J; Rangarajan S; Teo K; Yusuf S;
Ann Neurol; 2015 Feb; 77(2):251-61. PubMed ID: 25428654
[TBL] [Abstract][Full Text] [Related]
45. Cortical and frontal atrophy are associated with cognitive impairment in age-related confluent white-matter lesion.
Mok V; Wong KK; Xiong Y; Wong A; Schmidt R; Chu W; Hu X; Leung EY; Chen S; Chen Y; Tang WK; Chen X; Ho CL; Wong KS; Wong ST
J Neurol Neurosurg Psychiatry; 2011 Jan; 82(1):52-7. PubMed ID: 20826875
[TBL] [Abstract][Full Text] [Related]
46. Measures of brain morphology and infarction in the framingham heart study: establishing what is normal.
DeCarli C; Massaro J; Harvey D; Hald J; Tullberg M; Au R; Beiser A; D'Agostino R; Wolf PA
Neurobiol Aging; 2005 Apr; 26(4):491-510. PubMed ID: 15653178
[TBL] [Abstract][Full Text] [Related]
47. Prevalence of sarcopenia and predictors of skeletal muscle mass in nonobese women who are long-term users of estrogen-replacement therapy.
Kenny AM; Dawson L; Kleppinger A; Iannuzzi-Sucich M; Judge JO
J Gerontol A Biol Sci Med Sci; 2003 May; 58(5):M436-40. PubMed ID: 12730253
[TBL] [Abstract][Full Text] [Related]
48. Cerebral small-vessel disease and progression of brain atrophy: the SMART-MR study.
Kloppenborg RP; Nederkoorn PJ; Grool AM; Vincken KL; Mali WP; Vermeulen M; van der Graaf Y; Geerlings MI;
Neurology; 2012 Nov; 79(20):2029-36. PubMed ID: 23115210
[TBL] [Abstract][Full Text] [Related]
49. Cerebral magnetic resonance findings during enzyme replacement therapy in mucopolysaccharidosis.
Matsubara Y; Miyazaki O; Kosuga M; Okuyama T; Nosaka S
Pediatr Radiol; 2017 Nov; 47(12):1659-1669. PubMed ID: 28733853
[TBL] [Abstract][Full Text] [Related]
50. The association of antihypertensive agents with MRI white matter findings and with Modified Mini-Mental State Examination in older adults.
Heckbert SR; Longstreth WT; Psaty BM; Murros KE; Smith NL; Newman AB; Williamson JD; Bernick C; Furberg CD
J Am Geriatr Soc; 1997 Dec; 45(12):1423-33. PubMed ID: 9400550
[TBL] [Abstract][Full Text] [Related]
51. Prevalence, incidence, and risk factors of lacunar infarcts in a community sample.
Chen X; Wen W; Anstey KJ; Sachdev PS
Neurology; 2009 Jul; 73(4):266-72. PubMed ID: 19636046
[TBL] [Abstract][Full Text] [Related]
52. Retinal vessel diameters and cerebral small vessel disease: the Rotterdam Scan Study.
Ikram MK; De Jong FJ; Van Dijk EJ; Prins ND; Hofman A; Breteler MM; De Jong PT
Brain; 2006 Jan; 129(Pt 1):182-8. PubMed ID: 16317022
[TBL] [Abstract][Full Text] [Related]
53. Brain structural change and gait decline: a longitudinal population-based study.
Callisaya ML; Beare R; Phan TG; Blizzard L; Thrift AG; Chen J; Srikanth VK
J Am Geriatr Soc; 2013 Jul; 61(7):1074-9. PubMed ID: 23796055
[TBL] [Abstract][Full Text] [Related]
54. Medicare Expenditure Correlates of Atrophy and Cerebrovascular Disease in Older Adults.
Last BS; García Rubio MJ; Zhu CW; Cosentino S; Manly JJ; DeCarli C; Stern Y; Brickman AM
Exp Aging Res; 2017; 43(2):149-160. PubMed ID: 28230421
[TBL] [Abstract][Full Text] [Related]
55. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging.
Kawas C; Resnick S; Morrison A; Brookmeyer R; Corrada M; Zonderman A; Bacal C; Lingle DD; Metter E
Neurology; 1997 Jun; 48(6):1517-21. PubMed ID: 9191758
[TBL] [Abstract][Full Text] [Related]
56. Hormone replacement therapy, brain volumes and white matter in postmenopausal women aged 60-64 years.
Low LF; Anstey KJ; Maller J; Kumar R; Wen W; Lux O; Salonikas C; Naidoo D; Sachdev P
Neuroreport; 2006 Jan; 17(1):101-4. PubMed ID: 16361959
[TBL] [Abstract][Full Text] [Related]
57. Brain volumes in late life: gender, hormone treatment, and estrogen receptor variants.
Ryan J; Artero S; Carrière I; Scali J; Maller JJ; Meslin C; Ritchie K; Scarabin PY; Ancelin ML
Neurobiol Aging; 2014 Mar; 35(3):645-54. PubMed ID: 24269019
[TBL] [Abstract][Full Text] [Related]
58. Silent brain infarction on magnetic resonance imaging and neurological abnormalities in community-dwelling older adults. The Cardiovascular Health Study. CHS Collaborative Research Group.
Price TR; Manolio TA; Kronmal RA; Kittner SJ; Yue NC; Robbins J; Anton-Culver H; O'Leary DH
Stroke; 1997 Jun; 28(6):1158-64. PubMed ID: 9183343
[TBL] [Abstract][Full Text] [Related]
59. Vascular Risk Factors and Findings on Brain MRI of Elderly Adult American Indians: The Strong Heart Study.
Shibata D; Suchy-Dicey A; Carty CL; Madhyastha T; Ali T; Best L; Grabowski TJ; Longstreth WT; Buchwald D
Neuroepidemiology; 2019; 52(3-4):173-180. PubMed ID: 30677776
[TBL] [Abstract][Full Text] [Related]
60. Estrogen replacement therapy and ovarian cancer.
Folsom AR; Anderson JP; Ross JA
Epidemiology; 2004 Jan; 15(1):100-4. PubMed ID: 14712153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
